Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01712087 · ClinicalTrials.gov registry record
Long-term Surveillance of the MedStream Programmable Infusion System
A clinical trial, sponsored by Codman & Shurtleff.
- Terminated
- Registry status
- 2
- Enrollment target
NCT01712087 is a clinical trial that was terminated before completion, run by Codman & Shurtleff. The registered enrollment target is 2 participants.
The verdict
NCT01712087 was terminated before completion, sponsored by Codman & Shurtleff.
- TERMINATED
- Registry status
- 2 participants
- Enrollment target
Study Summary
This post-approval study will primarily evaluate the long-term safety of the MedStream Programmable Infusion System when used in combination with Baclofen for the treatment of severe spasticity. A secondary objective, to assess long-term effectiveness, based on the observed scores on the Ashworth Scale (rigidity for the lower extremities) and their Spasm Scores over the 36-month follow-up period will also be described.
Interventions
- DEVICE MedStream Programmable Infusion System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2012-10-01 |
| Est. Completion | 2017-12-17 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01712087
The ClinicalTrials.gov registry entry for NCT01712087 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Codman & Shurtleff, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MedStream Programmable Infusion System is the first listed.
NCT01712087 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01712087 about?
NCT01712087 is a clinical study titled "Long-term Surveillance of the MedStream Programmable Infusion System". This post-approval study will primarily evaluate the long-term safety of the MedStream Programmable Infusion System when used in combination with Baclofen for the treatment of severe spasticity. A secondary objective, to assess long-term effectiveness, based on the observed scores on the Ashworth Sc...
What is the current status of trial NCT01712087?
This trial is currently terminated. The enrollment target is 2 participants. The study started on 2012-10-01. Estimated completion is 2017-12-17.
What interventions are being tested in trial NCT01712087?
The interventions under investigation include: MedStream Programmable Infusion System (DEVICE).
Who is sponsoring clinical trial NCT01712087?
This trial is sponsored by Codman & Shurtleff, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.